Stocktoria

Benitec Biopharma Inc. BNTC

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-07-11

Benitec Biopharma Inc. statistics & valuation

Market cap$425.0M
P / B2.4×
Return on equity-25.7%
Return on capital-28.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20192020202120222023202420252026
Operating margin (%)
21.20% -8118.60% -23044.10% -24457.50% -25441.30% 20192020202120222023202420252026
Return on equity (%)
15.70% -80.80% -69.40% -631.80% -9684.20% -46.00% -39.00% -25.70% 20192020202120222023202420252026
Shares outstanding
856765 1.1M 8.2M 480688 1.7M 18.4M 36.2M 46.6M 20192020202120222023202420252026
Net debt ($)
20192020202120222023202420252026
Share buybacks ($)
20192020202120222023202420252026
Return on assets (%)
13.60% -71.40% -64.90% -304.80% -438.20% -41.70% -38.10% -24.90% 20192020202120222023202420252026
Free cash flow margin (%)
36.00% -7480.40% -22123.70% -21797.30% -24017.30% 20192020202120222023202420252026
Debt / equity (×)
20192020202120222023202420252026
EPS ($)
-$3.23 -$37.88 -$14.12 -$1.22 -$1.05 -$0.98 20192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin———-25441.3%-24457.5%-23044.1%-8118.6%21.2%
Net margin———-26082.7%-24942.5%-23528.8%-8111.8%21.4%
FCF margin———-24017.3%-21797.3%-22123.7%-7480.4%36.0%
Return on assets-24.9%-38.1%-41.7%-438.2%-304.8%-64.9%-71.4%13.6%
Return on equity-25.7%-39.0%-46.0%-9684.2%-631.8%-69.4%-80.8%15.7%
Current ratio34.0054.6710.490.941.9015.059.517.10

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.